Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
The success of cancer therapy is often compromised by the narrow therapeutic index of many anticancer drugs and the occurrence of drug resistance. The association of anticancer therapies with natural compounds is an emerging strategy to improve the pharmaco-toxicological profile of cancer chemothera...
Main Authors: | Cinzia Calcabrini, Francesca Maffei, Eleonora Turrini, Carmela Fimognari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00567/full |
Similar Items
-
Discovery of Sulforaphane as an Inducer of Ferroptosis in U-937 Leukemia Cells: Expanding Its Anticancer Potential
by: Giulia Greco, et al.
Published: (2021-12-01) -
Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
by: Bethsebie Lalduhsaki Sailo, et al.
Published: (2024-01-01) -
Anticancer properties of sulforaphane: current insights at the molecular level
by: Muhammad Asif Ali, et al.
Published: (2023-06-01) -
Sulforaphane and Its Bifunctional Analogs: Synthesis and Biological Activity
by: Łukasz Janczewski
Published: (2022-03-01) -
Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model
by: Anna Pogorzelska, et al.
Published: (2023-05-01)